CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies, today announced that members of the management team will participate in the 24th Annual Credit Suisse Healthcare conference on Tuesday, November 10th with a fireside chat at 8:30 a.m. MT/10:30 a.m. ET. The conference is being held at the Phoenician Hotel in Scottsdale, Arizona.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
